Has Brigitte Hurtubise, MD received payments from drug or device companies?

Yes. Drug and device makers reported $90,698 in general payments to Brigitte Hurtubise, MD across 28 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brigitte Hurtubise, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brigitte Hurtubise, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brigitte Hurtubise, MD

Neurology · Los Angeles, CANPI 1720432404

Payments from drug & device makers

What this record shows

This record is dominated by grants: $89,999 of the $90,698 with a category attached, or 99.2%. Biogen accounts for 99.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $90,393 and has fallen 99.8% since, to $192 in 2022. Among neurology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$90,698in general payments, 2019–2025

Across 28 payments — averaging $3239.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biogen$90K
Novartis$507
EMD Serono, Inc.$55
Sanofi$47
AstraZeneca$39

What the payments were for

Grants$89,99999%
Food & beverage$6991%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biogen	2	$90,049
Novartis	20	$507
EMD Serono, Inc.	3	$55
Sanofi	2	$47
AstraZeneca	1	$39

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KESIMPTA$125

How this compares

$90,698 in reported general payments places this provider in the 90th percentile of 1,996 neurology providers in California.

See all neurology providers in California →

Medicare billing

Part B allowed, 2024

$8,062

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Nurtec OdtRimegepant Sulfate	29	$38,165
Dalfampridine ErDalfampridine	13	$13,788
Emgality PenGalcanezumab-Gnlm	14	$11,135
Emgality SyringeGalcanezumab-Gnlm	13	$8,541
Lacosamide	31	$7,839
Levetiracetam	49	$2,568
Oxcarbazepine	11	$1,359
Gabapentin	52	$1,344
Carbidopa-LevodopaCarbidopa/Levodopa	15	$848
Amitriptyline Hcl	17	$323
Baclofen	14	$320
Topiramate	13	$288
Primidone	13	$277
Famotidine	13	$228
Nortriptyline Hcl	12	$180

Paid to pharmacies, not to this prescriber.

Other neurology in Los Angeles

Perry ShiehLos Angeles$2.4M
David LiebeskindLos Angeles$1.9M
John SternLos Angeles$999K
Jeffrey CummingsLos Angeles$918K
Alan RapoportLos Angeles$808K
Alon AvidanLos Angeles$505K
Mark LewLos Angeles$450K
Dawn EliashivLos Angeles$364K
Richard LewisLos Angeles$309K
Margaret BurnettLos Angeles$293K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →